Speaker illustration

Doctor Ahmed Farouk Mohamed Elamin

Liverpool Heart and Chest Hospital, Liverpool (United Kingdom of Great Britain & Northern Ireland)

Potential use of PCSK9 inhibitors in secondary prevention for patients with treated acute coronary syndrome. A study from a large UK university teaching hospital

Event: EuroPrevent 2017

Topic: Lipids

Session: Diabetes/ Lipids/Obesity/Nutrition_Part 2


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb